Skip to content

DR. DERVAUX

Active Private limited companyfounded 2008active for 18 yearsKarel Oomsstraat 22, 2018 AntwerpKBO/BCE: BE 0896.696.704

Lifetime

18 annual accounts with figures on one time axis
peak of €318,690 in 2024
€302,643▼ 5.0%
peak of €213,545 in 2024
€203,994▼ 4.5%
peak of €1.0m in 2025
€1.0m▲ 7.0%
€33,709▼ 30.0%
Board2 names since 2018
1 director
Documentsfilings and deeds
24-09-202655 days late
2025micro format
Dividend €135,723Debts from €48,131 to €33,709

Key points

from the 2025 annual accounts

Equity

€1.0m ▲ 7.0%
1.02024+0.2Profit-0.1Dividend1.02025

DR. DERVAUX paid out €135,723 in dividends. That is 67% of the 2025 profit.

Filings

18 annual accounts since 2008
AprilJune31 JulyOctober2010201520202025

Ten of the last ten came late. The 2019 accounts came in latest, 88 days after the end of the period.

Position in the sector

96.9%

Higher solvency than 94% of companies in human health. Sector median 63.0% · 21,347 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,816 companies had the same profile as DR. DERVAUX has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,816 companies, not a prediction for DR. DERVAUX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0896696704
changes role from manager to director Legal-form conversion: to private limited company · Director discharge: · General meeting of 03-05-2023 · Gazette deed
appointed as manager General meeting of 06-06-2017 · Gazette deed
Incorporation published on 07-04-2008 · Gazette deed
All 31 events

Comparable companies

same main activity, similar in size and age
Company
DR. DERVAUX Antwerp €1.1m €302,643 96.9% -
Dr. J. van Dongen Antwerp €1.0m €274,255 78.0% -
Libeer Christophe BV Bonheiden €1.0m €288,699 72.5% -
DR.JAN MYNCKE Lier €1.1m €280,911 92.0% -
DOKTER BART BRYON Zandhoven €1.0m €281,171 90.0% -
DR. P. VAN HAUTHEM Mechelen €1.2m €291,998 56.1% -
DR ANDY IUDICELLO Westerlo €1.0m €302,366 82.4% -

These companies have the same main activity as DR. DERVAUX: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €983,000 and €1.2m, founded between 2007 and 2010.

Official details

Source: KBO
Status
Active since 26-03-2008Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.301.991.5282018 Antwerp, since 26-03-2008
Financial year end
31 December
Peppol
Reachable since 27-03-2026
Company details

Annual accounts 2025

≈ €460,000estimated
€1.1m▲ 5.2%
Filing
Filed on 24-09-2026
Financials

Insights on DR. DERVAUX

DR. DERVAUX files the micro format. That format states no turnover. The gross margin rose from €41,562 in 2008 to €302,643 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. DERVAUX

What is the company number of DR. DERVAUX?
The company number of DR. DERVAUX is 0896.696.704. The VAT number is the same number with BE in front: BE 0896.696.704.
Where is DR. DERVAUX based?
The registered office is at Karel Oomsstraat 22, 2018 Antwerp.Company details
What does DR. DERVAUX do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. DERVAUX?
DR. DERVAUX is a private limited company (BV).
When was DR. DERVAUX founded?
DR. DERVAUX was founded on 26-03-2008.
Is DR. DERVAUX still active?
Yes, DR. DERVAUX is an active enterprise in the KBO register.
What is the turnover of DR. DERVAUX?
The turnover in financial year 2025 is ≈ €460,000. This figure is estimated from the gross margin of €302,643 and 31 comparable companies (NACE 86220). It probably lies between €400,000 and €630,000.Financials
Is DR. DERVAUX profitable?
In financial year 2025, DR. DERVAUX made a profit of €203,994.
Where can I find the annual accounts of DR. DERVAUX?
DR. DERVAUX filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. DERVAUX due?
DR. DERVAUX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.